These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Formulary management to reduce cost: P & T committee strategies. Roberts MJ; Summerfield MR Hosp Formul; 1986 Apr; 21(4):481-3, 488-92. PubMed ID: 10276289 [TBL] [Abstract][Full Text] [Related]
3. Application of decision analysis to drug selection for formulary addition. Kresel JJ; Hutchings HC; MacKay DN; Weinstein MC; Read JL; Taylor-Halvorsen K; Ashley H Hosp Formul; 1987 Jul; 22(7):658-63, 673, 676. PubMed ID: 10282682 [TBL] [Abstract][Full Text] [Related]
4. Computer-based system for maintaining and printing a hospital formulary. Sateren LA; Sudds TW; Tyler LS Am J Hosp Pharm; 1987 Jun; 44(6):1367-70. PubMed ID: 3618614 [TBL] [Abstract][Full Text] [Related]
5. Financial impact of formulary revision of second-generation cephalosporins. Andrews JD; Hafting S Can J Hosp Pharm; 1988 Jun; 41(3):125-7. PubMed ID: 10288499 [TBL] [Abstract][Full Text] [Related]
6. Cost savings through formulary implementation and group purchasing in four therapeutic categories. Sylvester KL; Wudds TW Hosp Formul; 1986 Mar; 21(3):357-60, 369-70. PubMed ID: 10275579 [TBL] [Abstract][Full Text] [Related]
8. Drug Products Information File simplifies computer applications. Dougherty FK Am J Hosp Pharm; 1971 Jun; 28(6):461-4. PubMed ID: 5124730 [No Abstract] [Full Text] [Related]
9. Centralized drug list production in a multihospital system. Hooper JK Am J Hosp Pharm; 1976 Jul; 33(7):653-8. PubMed ID: 941921 [TBL] [Abstract][Full Text] [Related]
10. Cost effectiveness of an enteral products formulary. Durfee DD; Skinner-Domet VM Am J Hosp Pharm; 1984 Nov; 41(11):2352-4. PubMed ID: 6439034 [TBL] [Abstract][Full Text] [Related]
11. Prospective reimbursement and DRGs: implications for formulary management. Enright SM Hosp Formul; 1983 Oct; 18(10):989-90, 999-1000. PubMed ID: 10310246 [No Abstract] [Full Text] [Related]
13. Hospital formularies: organizational aspects and supplementary components. Rucker TD; Visconti JA Am J Hosp Pharm; 1976 Sep; 33(9):912-7. PubMed ID: 984056 [TBL] [Abstract][Full Text] [Related]
14. Some legal aspects of the hospital formulary system. Fink JL Am J Hosp Pharm; 1974 Jan; 31(1):86-90. PubMed ID: 4589389 [No Abstract] [Full Text] [Related]
15. Measurement of formulary inclusion costs. Myers CE; Pierpaoli P; Smith MA Hosp Formul; 1981 Sep; 16(9):951-3, 957-8, 967-8 passim. PubMed ID: 10252372 [No Abstract] [Full Text] [Related]
16. Reducing the number of formulary theophylline preparations. Anandan JV Am J Hosp Pharm; 1981 Apr; 38(4):511-3. PubMed ID: 7282676 [TBL] [Abstract][Full Text] [Related]
17. Evaluating a restrictive formulary system by assessing nonformulary-drug requests. Green JA; Chawla AK; Fong PA Am J Hosp Pharm; 1985 Jul; 42(7):1537-41. PubMed ID: 4025350 [TBL] [Abstract][Full Text] [Related]
18. The long-term value of the selected list as a method of controlling drug costs in a district general hospital. Upton DR; Holmes GK; Fox PD; Cullen AM; Poston JW Health Trends; 1989 Feb; 21(1):26-9. PubMed ID: 10292126 [TBL] [Abstract][Full Text] [Related]
19. Achieving parenteral nutrition cost savings through prescribing guidelines and formulary restrictions. Maswoswe JJ; Newcomer DR; Quandt CM Am J Hosp Pharm; 1987 Jun; 44(6):1376-81. PubMed ID: 3113237 [TBL] [Abstract][Full Text] [Related]